Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
10 March 2021

GenSight Biologics Reports Full Year 2020 Financial Results and provides an Outlook on 2021

17 Apr 2021 - 22 Apr 2021

2021 AAN Annual Meeting, virtual

06 Apr 2021 - 09 Apr 2021

Cell & Gene Meeting on the Mediterranean, virtual

25 Mar 2021

Ophthalmology Future Forums – Asian Retina Virtual Forum

15 February 2021

GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs

22 Feb 2021 - 25 Feb 2021

4th Annual Gene Therapy for Rare Disorders – virtual

18 Feb 2021

OIS Gene Therapy Innovation Showcase – virtual

06 Feb 2021 - 07 Feb 2021

44th Annual Macula Society Meeting – Virtual

04 February 2021

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non Human Primates

19 January 2021

GenSight Biologics Reports Cash Position as of December 31, 2020 and Provides Operational Update

  • View previous 9 articles
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page